ACUTE VIRAL HEPATITIS CLINICAL PRESENTATION. DIGNOSIS.

Slides:



Advertisements
Similar presentations
Bloodborne Pathogens Sandy Bennett.
Advertisements

Viral hepatitis (B, C, D, G) Dr. Abdulkarim Alhetheel
Hepatitis B.
Hepatitis B and Hepatitis B Vaccine Epidemiology and Prevention of Vaccine- Preventable Diseases National Center for Immunization and Respiratory Diseases.
H EPATITIS VIRUS A & B Presented By: Dora Amoako Gerardo Castro.
Blood-borne hepatitis ( parenterally transmitted hepatitis)
Acute Viral Hepatitis. Viral Hepatitis Infectious: Hepatitis A Infectious: Hepatitis A Serum : Hepatitis B, D Serum : Hepatitis B, D NANB : Hepatitis.
FECAL-BORNE HEPATITIS. ETIOLOGY Hepatitis A virus (HAV), Hepatovirus Picornavirus, enterovirus nm 1 serotype only, although there are 4 genotypes.
Epidemiology and Control Programs for HBV Infection. Yousef Qari, MD, FRCP(C), ABIM Gastoenterologist King Abdulaziz University Hospital.
Iva Pitner Mentor: A. Žmegač Horvat
Hepatitis web study H EPATITIS W EB S TUDY H. Nina Kim, MD Assistant Professor of Medicine Division of Infectious Diseases University of Washington School.
HEPATITIS A VIRUS Week Response Clinical illness ALT IgM IgG HAV in stool Infection Viremia EVENTS IN HEPATITIS A VIRUS INFECTION.
Kerriann Parchment GI CBL 2 Part 3 December 2012 Viral hepatitis serology.
Hepatitis B Virus 28.
. In the name of God In the name of God. Epidemio logy.
Adult Medical- Surgical Nursing
(+) Stranded RNA Viruses III
DR. MOHAMMED ARIF. ASSOCIATE PROFESSOR CONSULTANT VIROLOGIST HEAD OF THE VIROLOGY UNIT Enterically transmitted hepatitis (Water-borne hepatitis)
Hepatitis B and Acute Liver Failure Jack Kuritzky, PGY-2 UNC Internal Medicine Morning Report 3/12/10.
Why we are here? However, a general lack of understanding exists among health-care professionals regarding the interpretation of screening test results,
Acute Parenchymal Disease of Liver Acute Hepatitis Inflammation of liver caused by various agents Viral infections Viral infections Hepatitis A Virus Hepatitis.
Viral Hepatitis Australian Family Physician Vol. 30 No.5, May 2001 Presented by 郭詠怡 Date presented:25/8/2003.
Hepatitis B Virus Dr R V S N Sarma., M.D., [SLIDE 1] Title Slide
ACUTE VIRAL HEPATITIS CLINICAL PRESENTATION. DIGNOSIS. EPEDEMOLOGY OF VIRAL HEPATITIS INFECTION A,B,C IN KSA. MANAGEMENT.
ACUTE VIRAL HEPATITIS CLINICAL PRESENTATION. DIGNOSIS. EPEDEMOLOGY OF VIRAL HEPATITIS INFECTION A,B,C IN KSA. MANAGEMENT.
21/2/ Viral Hepatitis B (HBV) Associate Professor Family and Community Medicine Department King Saud University.
Blood borne hepatitis By: Dr. Mona Badr Assistant Professor & Consultant Virologist.
+ By: Sydney Freedman. + General Background 1895: Germany, smallpox outbreak Led to Jaundice Liver doesn’t destroy blood cells properly 1942: United States,
GI BLOCK; This practical class is designed and Prepared by: Prof. Samy A. Azer (Medical Education) Dr. Ali Somily (Microbiology) Prof. Abdul Mageed.
Hepatitis Dr. Meg-angela Christi M. Amores. Hepatitis Inflammation of the liver Acute Viral Hepatitis Toxic and Drug-induced Hepatitis Chronic Hepatitis.
What is Hepatitis? General: inflammation of liver parenchyma cells
Hepatitis C Dr R V S N Sarma., M.D Consultant Physician.
Hepatitis B Fahad Alanazi.
CHRONIC HEPATITIS B SEROLOGY
Acute Liver Failure Tutorial Ayman Abdo. Objectives After the discussion in this educational exercise, I want you to be able to : Identify common causes.
Viral hepatitis overview Itodo Ewaoche 27/02/2015.
Hepatitis A, B, C: Overview, Serologies, and Vaccination Connie Tien June 6, 2016.
MICROBIOLOGY IRS. Gastroenteritis 1) Major cause of infantile death 2) Feacal-oral transmission 3) Gastroenteritis cause dehydration 4) 50 % of all causes.
HBV. Overview of the Epidemiology of Hepatotropic Viruses.
Viral Hepatitis.
VIRAL HEPATITIS BY DR. TARUN S. CHOUDHARY, MD. PLAN OF PRESENTATION  Introduction of the disease  Epidemiology  Brief details of the virus involved.
Viral Hepatitis Andy King Consultant Gastroenterologist/Hepatologist
Hepatitis B and C Dr. Asif Rehman.
Hepatitis C.
By: DR.Abeer Omran Consultant pediatric infectious disease
Hepatitis Gail Lupica PhD, RN, CNE.
Viral hepatitis (B, C, D, G) Dr. Abdulkarim Alhetheel
Hepatitis Tutoring By Alaina Darby.
In The Name of God.
Presenter ITODO EWAOCHE
Dr. Nadia Aziz C.A.B.C.M. Department of community medicine
MICROBIOLOGY PRACTICAL
ACUTE VIRAL HEPATITIS CLINICAL PRESENTATION. DIGNOSIS.
MICROBIOLOGY PRACTICAL
Viral hepatitis Abdullah Alyouzbaki
The virus that does not cause chronic liver disease
is caused by the Hepatitis A virus (HAV)
ACUTE VIRAL HEPATITIS CLINICAL PRESENTATION. DIGNOSIS.
Causes , Symptoms, Diagnosis Treatment & Prevention .
Viral hepatitis (B, C, D, G) Dr. Abdulkarim Alhetheel
Dr. Mohd. Shaker An Overview
MICROBIOLOGY PRACTICAL
Case Definition: HEPATITIS C
Chronic viral hepatitis type B and chronic delta
RISK R isk of Perinatal and Early Childhood Infection
HEPATITIS C BY MBBSPPT.COM
Clinicaloptions.com/hepatitis Using Virologic and Serologic Tests in the Management of Hepatitis B Diagnose chronic HBV infection When in slideshow mode,
CLINICAL SOLVING PROBLEM
College of Medicine & KKUH
Presentation transcript:

ACUTE VIRAL HEPATITIS CLINICAL PRESENTATION. DIGNOSIS. EPEDEMOLOGY OF VIRAL HEPATITIS INFECTION A,B,C IN KSA. MANAGEMENT.

Diagnosis of hepatitis Patient history Physical examination Liver function tests Serologic tests

Symptoms and Signs Pre-icteric phase Anorexia Fatigue Nausea Vomiting Arthralgia Myalgia Headache Photophobia Pharangitis

Icteric phase:: Enlarged liver Tender upper quadrant Discomfort Splenomegaly (10-20%) General adenopathy Post-icteric phase

Lab Findings L FT increase >5-10 times of normal Markers of hepatitis B or C or A might be positive

DD: Infectious Mononucleosis Drug Induced Hepatitis Chronic Hepatitis. Alcohol Hepatitis Cholecystitis, Cholelithiasis 6-Auto-immun hepatitis

MARKERS OF VIRAL HEPATITIS HBV MARKERS HCV MARKERS HAV MARKERS

Hepatitis B Markers anti-HBc exposure (IgM = acute) HBsAg  infection (carrier) anti-HBs  immunity HBeAg  viral replication anti-HBe  seroconversion HBV-DNA  viral replication:

Hepatitis C Markers ANTI -HCV PCR-RNA HCV

Hepatitis A Markers HAV igM HAV igG

Hepatitis E Markers HEV igM HEV igG HEV RNA PCR

AUTOIMMUN HEPATITIS MARKERS ANF ANTI MITOCHONDRIAL AB ANTI SMOOTH MUSCLES ABS.

AUTOIMMUN HEPATITIS MARKERS ANA) ANTI MITOCHONDRIAL ANTI SMOOTH MUSCLES ABS

INCIDENCE OF ACUTE HEPATITIS IN 5 HEPATOLOGY CLINICS IN KSA 2013 Causes of Hepatitis HAV HBV HCV AIH DILI KKUH 7 3 1 11 ? NGH 10 5 2 8 AMC KFH DAMMAM UN. TOTAL 21 4 26 16

Complications 1.Chronic hepatitis  cirrhosis- HCC 2.Fulmnant hepatitis

FULMINANT HEPATITIS Definition: Hepatic Failure Within 8 Weeks Of Onset Of Illness. Manifestation: Encephalopathy and Prolonged PT Histopathology: Massive Hepatic Necrosis.

Natural History Gow, BMJ 2001

Possible transmission route of HBV in KSA 1-Horisontal transmission (person to person) is the main transmission route 2-Perintal transmission (positive HBSAG mothers) especially if they are HBEAG positive 3- Heterosexual transmission 4-Illegal injection drug use 5- Contaminated equipment used for therapeutic injections and other health care related procedures 6- Folk medicine practice 7-Blood and blood products transfusion without prior screening

HBV INFECTION before and after vaccination program

Al-Faleh. Annals of Saudi Medicine, 1988 OVERALL PREVALENCE OF HBsAg AMONG SAUDIS IN THE 80’S ACCORDING TO REGIONS Positivity (%) Al-Faleh. Annals of Saudi Medicine, 1988

Al-Faleh, Annals of Saudi Medicine, 1988 PREVALENCE OF HBeAg AMONG HBsAg POSITIVE SAUDIS PREGNANT WOMEN (n = 20920) Al-Faleh, Annals of Saudi Medicine, 1988

FREQUENCY OF HBeAg AMONG HBsAg POSITIVE SAUDI CHILDREN (n=307) Al-Faleh et al. Journal of Infection, 1992

PREVENTION STRATEGIES OF MINISTRY OF HEALTH IN KSA Introducing HBV vaccine in EPI program; and Mandatory screening of blood donors and expatriates. Vaccination of risk groups. Health education especially among medical personnel.

History of HBV infection control in KSA 1989 1990 1990- until now 1990- until now Vaccination of All infants At birth Vaccination of all children at school entry vaccination of All risk groups mandatory Screening of all Expatriates coming To work in KSA 27

THE CURRENT EPI IN THE KINGDOM OF SAUDI ARABIA At birth BCG + HB1 At 6 weeks DPT1 + OPV1 Hb2 At 3 months DPT2 + OPV2 At 5 months DPT3 + OPV3 At 5months Measles HB3 At 12 months MMR At 18 months (DPT + OPV) Booster 1 At 4-6 years (DPT + OPV) Booster 2

COMPARISON OF PREVALENCE OF HBsAg AMONG SAUDI CHILDREN IN 1989 (n=4575) AND 1997 (n=5355) – ACCORDING TO AGE Al Faleh, J Infect 1999

COMPARISON OF PREVALENCE OF HBsAg AMONG SAUDI CHILDREN IN 1989 (n=4575) AND 1997 (n=5355) – ACCORDING TO REGION Al Faleh, J Infect 1999

Prevalence Of HBsAg Among Saudi Population Before & After Vaccination over 18 y Age numbers 1-10yr 4575 1-2yr 637 1-12yr 3666 16-18yr 1365 31

Long Term Seroconversion Rate Over 18 Years (Anti-HBS) * ** *** Age N 1-2yr 637 1-12yr 3666 16-18yr 1365 * Al Faleh et al Annals of Saudi meds 1993 ** Al Faleh et al Journal of infection 1999 *** AlFaleh et al journal of infection2008 32

Long-Term protection of HB- vaccine over 18 years ( anti-HBS>10IU/L)(n=1355) Age Region 1-2yr 5 1-8yr 13 16-18yr 3 AL Faleh et al, J Infection 2008

CHANGING PATTERNS OF HBsAg POSITIVITY AMONG BLOOD DONORS IN MOH,CENTRAL BLOOD BANK 1994-2005

PREVALENCE OF HBsAg POSITIVITY AMONG BLOOD DONORS IN KKUH FROM 1987 TO 2008

برنامج الزواج الصحيPRI-MARITALSCREENING التهاب الكبد ب وج 1429-1435هـ HBV,HCV INFECTION FROM2009-2014 عدد المتقدمين NR.OF SCREENDS HIV الكبد ج HCV الكبد ب HBV 2.131.018 512 5388 24103 0.02 % 0.3% 1%

عدد حالات التهاب الكبد ب وج1429-1435هـ NR عدد حالات التهاب الكبد ب وج1429-1435هـ NR.OF POSITIVE HBV&HCV CASES(2009-2014) HCV=RED

Case report. 5/11/16 Ahmed is 16 Y/O student ,living in TABUK, C/O abdominal discomfort, nausea, Bloody diarrhea for 1 year. O/E : Lower abdominal pain His mother is positive for HBsAG &HBeAG.

Lab. results 12/11/16 : ALT 40/L(21-72) AST 30 U/L (17-59) ALKALINE PHOSPHATASE 80.0 U/L. YGT 40,0U/L BIL.1MG/DL (0.0-1.4) ALB.4.6 g/l(3.5-5.0) INR (NORMAL) PLT:88000(150000-400000)

Lab. results HBsAG : POSITVE PCR QUANTITATIVE :200IU/ML

Lab. results HBsAG : POSITVE PCR QUANTITATIVE :200IU/ML

FINAL DIAGNOSIS CARRIER OF VIRAL HEPATITS B

Why this young boy is positive for hepatitis B? He was not vaccinated at birth? He was vaccinated at birth, but did not Completed the 3 doses ? He was vaccinated at birth but did not Received Hyperimmune globulin at birth? He did not respond to the 3 doses of Vaccine ?

HCV INFECTION

Natural history Marcellin, J Hepat 1999

Diagnostic test only by 1st-generation EIA kit. Overall prevalence rate of HCV infection in KSA among children and adolescent during the last 18 yrs. 1989 1997 2008 No. of children Positive (%) No. of students 4496 39* (0.87%) 5350 2** (0.04%) 1357 (5)3 0.22% Diagnostic test only by 1st-generation EIA kit. Diagnostic test by 3rd-generation EIA kit and confirmatory test by RIBA kit. Diagnostic test by PCR for anti- HCV Positive cases. * ALFaleh et al. Hepatology 1991 ** ALFaleh Ann Saudi Med. 2003 48

Prevention Of HCV Transmission Avoiding shared use of Razors or brushes and any item that pierces the skin. Strict adherence of the universal precautions in health facilities. Educating and training of HCW’s to the proper use of standard precautions Folk medicine?!

HAV INFECTION

Al-Faleh et al. Saudi Med. J, 1999 COMPARISON OF PREVALENCE OF ANTI-HAV AMONG SAUDI CHILDREN IN 1989 (n=4375) AND 1997 (n=5255) – ACCORDING TO AGE Al-Faleh et al. Saudi Med. J, 1999 1

COMPARISON OF PREVALENCE OF ANTI-HAV AMONG SAUDI CHILDREN IN 1989 (n=4375) AND 1997 (n=5255) – ACCORDING TO REGION 1

Changing pattern of Hepatitis A prevalence within the Saudi population over 18 yrs * ** *** Age Region 1-10 YRS 13 1-12 yrs 13 16-18 yrs 3 *AlRashed R. Ann SM 1997 ** AlFaleh et al SMJ 1999 *** AlFaleh et al WJG 2008 56

THANK YOU